Cost-Effectiveness Analysis of Rehabilitation Strategies for Patients After Prostate Cancer Surgery
https://doi.org/10.35401/2541-9897-2025-10-2-87-95
Abstract
Objective: To compare cost-effectiveness of rehabilitation models for patients with urinary incontinence following radical prostatectomy.
Materials and methods: We evaluated direct costs of rehabilitation as part of the existing approach in patients with urinary incontinence following radical prostatectomy in the Yaroslavl Region and developed a rehabilitation strategy (artificial urethral sphincter placement). We conducted a comparative analysis of the direct costs of the strategies.
Results: The use of absorbent products for rehabilitation of patients with urinary incontinence following radical prostatectomy requires an average of 293300 (US $2650) per patient annually. The rehabilitation strategy with artificial urinary sphincter placement costs 486215 (US $4420) and results in a 65% increase in costs in the first year. However, in the second year of the rehabilitation program, artificial urinary sphincter placement has an obvious economic advantage, and within 10 years rehabilitation of a working-age patient using this strategy can save 2400000 (US $22244) (inflation expectations were not accounted for).
Conclusions: The implementation of the rehabilitation program involving artificial urinary sphincter placement for patients with urinary incontinence following radical prostatectomy has significant social and economic impacts.
About the Authors
A. V. Ukgarskiy
Nongovernmental Health Care Institution “Klinika sovremennoy meditsiny” LLC
Russian Federation
Russian Federation
Andrey V. Ukgarskiy - Cand. Sci. (Med.), Chief Physician, Nongovernmental Health Care Institution “Klinika sovremennoy meditsiny” LLC.
ulitsa Nekrasova 46, Yaroslavl, 150040
M. S. Los
City Clinical Hospital No. 8; Ivanovo State Medical University
Russian Federation
Russian Federation
Marina S. Los - Cand. Sci. (Med.), Chief Physician, City Clinical Hospital No. 8; Associate Professor at the Department of Urology and Nephrology, Ivanovo State Medical University.
Ivanovo
P. V. Nesterov
Regional Clinical Oncological Hospital
Russian Federation
Russian Federation
Pavel V. Nesterov - Cand. Sci. (Med.), Chief Physician, Regional Clinical Oncological Hospital.
Yaroslavl
Yu. S. Shakh-Paronyants
Regional Clinical Oncological Hospital
Russian Federation
Russian Federation
Yulia S. Shakh-Paronyants - Oncologist, Regional Clinical Oncological Hospital.
Yaroslavl
M. V. Kosenko
Yaroslavl State Medical University
Russian Federation
Russian Federation
Maxim V. Kosenko - Assistant Professor at the Department of Urology and Nephrology, Yaroslavl State Medical University.
Yaroslavl
References
1. Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8(12):e943–e955. PMID: 38000889. https://doi.org/10.1016/S2468-2667(23)00211-6
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. PMID: 38572751. https://doi.org/10.3322/caac.21834
3. Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020;58(3):326–339. PMID: 31714881. https://doi.org/10.1515/cclm-2019-0693
4. Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12(6):1807–1823. PMID: 30203706. PMCID: PMC6199451. https://doi.org/10.1177/1557988318798279
5. Alekseev BYa, Nyushko KM. Combination therapy for prostate cancer: clinical observations. Cancer Urology. 2012;(4):77–82. (In Russ.).
6. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. Malignant Neoplasms in 2020 Russia (Morbidity and Mortality). MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii; 2021. (In Russ.).
7. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. State of Cancer Care in 2023 Russia. MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii; 2024. (In Russ.).
8. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–629. PMID: 27568654. https://doi.org/10.1016/j.eururo.2016.08.003
9. Mohler JL, Armstrong AJ, Bahnson RR, et al. Prostate cancer, Version 1.2016. J Natl Compr Canc Netw. 2016;14(1):19–30. PMID: 26733552. https://doi.org/10.6004/jnccn.2016.0004
10. Aboyan IA, Orlov YuN, Shevchenko AN, Pakus SM, Hasigov AV. Urinary incontinence after radical prostatectomy: prognostic factors. Cancer Urology. 2021;17(1):159–166. (In Russ.). https://doi.org/10.17650/1726-9776-2021-17-1-159-166
11. Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191–206. PMID: 37202314. PMCID: PMC10851915. https://doi.org/10.1016/j.eururo.2023.04.021
12. Weber BA, Roberts BL, Mills TL, Chumbler NR, Algood CB. Physical and emotional predictors of depression after radical prostatectomy. Am J Mens Health. 2008;2(2):165–171. PMID: 19477780. https://doi.org/10.1177/1557988307312222
13. Kizlasov PS, Sokolshchik MM, Baikova NV, Samoilov AS, Zabelin MV. Urinary incontinence after radical prostatectomy (literature review). Experimental & Clinical Urology. 2015;(3):38–41. (In Russ.).
14. Hamdy FC, Donovan JL, Lane JA, et al; ProtecT Study Group. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547–1558. PMID: 36912538. https://doi.org/10.1056/NEJMoa2214122
15. MacKenzie KR, Davis J, Harding C, Aning JJ. Patient-reported outcomes and urodynamic findings in men with persistent lower urinary tract symptoms following robot-assisted radical prostatectomy. Neurourol Urodyn. 2019;38(5):1353–1362. PMID: 30980415. https://doi.org/10.1002/nau.23986
16. King AJ, Evans M, Moore TH, et al. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men’s experiences and unmet needs. Eur J Cancer Care (Engl). 2015;24(5):618–634. PMID: 25630851. PMCID: PMC5024073. https://doi.org/10.1111/ecc.12286
17. Al-Khariri МF, Loukianov IV. Urinary incontinence after radical retropubic prostatectomy. Vestnik Rossiiskogo nauchnogo tsentra rentgenoradiologii. 2013;(13–3):10. (In Russ.).
18. Wittmann D, Mehta A, McCaughan E, et al. Guidelines for sexual health care for prostate cancer patients: recommendations of an international panel. J Sex Med. 2022;19(11):1655–1669. Published correction appears in J Sex Med. 2023;20(5):704. PMID: 36192299. https://doi.org/10.1016/j.jsxm.2022.08.197
19. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–1395. PMID: 18454794. https://doi.org/10.1111/j.1464-410X.2008.07601.x
20. Mehnert A, Lehmann C, Graefen M, Huland H, Koch U. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl). 2010;19(6): 736–745. PMID: 19832893. https://doi.org/10.1111/j.1365-2354.2009.01117.x
21. Orlov AE, Yashkov AV, Sivokhina TA, et al. The correction of urinary incontience as a complication of prostate cancer radical treatment. Izvestiya Samarskogo nauchnogo tsentra Rossiiskoi akademii nauk. 2015;17(2–3):618–621. (In Russ.).
22. Nahon I. Physiotherapy management of incontinence in men. J Physiother. 2021;67(2):87–94. PMID: 33753017. https://doi.org/10.1016/j.jphys.2021.02.010
23. Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368(5):436–445. PMID: 23363497. PMCID: PMC3742365. https://doi.org/10.1056/NEJMoa1209978
24. Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):405–417. PMID: 22749852. https://doi.org/10.1016/j.eururo.2012.05.045
25. Ramazanov KK, Akhvlediani ND, Savchenko AV, Pushkar DY. Implantation of an artificial urinary sphincter for urinary incontinence after radical prostatectomy (current aspects). Andrology and Genital Surgery. 2022;23(1):21–29. (In Russ.). https://doi. org/10.17650/1726-9784-2022-23-1-21-29
26. Fultz NH, Rahrig Jenkins K, Østbye T, Taylor DH Jr, Kabeto MU, Langa KM. The impact of own and spouse’s urinary incontinence on depressive symptoms. Soc Sci Med. 2005;60(11):2537–2548. PMID: 15814179. https://doi.org/10.1016/j.socscimed.2004.11.019
27. Herranz-Amo F. Radical retropubic prostatectomy: preservation of urinary continence. Actas Urol Esp (Engl Ed). 2020;44(10):674–681. PMID: 32739124. https://doi.org/10.1016/j.acuro.2020.06.006
28. Azal W Neto, Capibaribe DM, Dal Col LSB, Andrade DL, Moretti TBC, Reis LO. Incontinence after laparoscopic radical prostatectomy: a reverse systematic review. Int Braz J Urol. 2022;48(3):389–396. PMID: 35168312. PMCID: PMC9060170. https://doi.org/10.1590/S1677-5538.IBJU.2021.0632
29. Yafi FA, Powers MK, Zurawin J, Hellstrom WJ. Contemporary review of artificial urinary sphincters for male stress urinary incontinence. Sex Med Rev. 2016;4(2):157–166. PMID: 27872025. https://doi.org/10.1016/j.sxmr.2015.11.004
30. Anderson CA, Omar MI, Campbell SE, Hunter KF, Cody JD, Glazener CM. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1(1):CD001843. PMID: 25602133. PMCID: PMC7025637. https://doi.org/10.1002/14651858.CD001843.pub5
31. Hudolin T, Kolar Mitrović H, Bakula M, et al. Pelvic rehabilitation for urinary incontinence after radical prostatectomy. Acta Clin Croat. 2022;61(Suppl 3):71–75. PMID: 36938558. PMCID: PMC10022410. https://doi.org/10.20471/acc.2022.61.s3.10
32. Tunn R, Baessler K, Knüpfer S, Hampel C. Urinary incontinence and pelvic organ prolapse in women. Dtsch Arztebl Int. 2023;120(5):71–80. PMID: 36647585. PMCID: PMC10080228. https://doi.org/10.3238/arztebl.m2022.0406
33. Alouini S, Memic S, Couillandre A. Pelvic floor muscle training for urinary incontinence with or without biofeedback or electrostimulation in women: a systematic review. Int J Environ Res Public Health. 2022;19(5):2789. PMID: 35270480. PMCID: PMC8910078. https://doi.org/10.3390/ijerph19052789
34. Rybalkina DKh, Dyusembaeva NK, Shpakov AE, Salimbaeva BM, Drobchenko EA, Imanbekov MM. Review of current epidemiologic aspects of oncopathology. Gigiena truda i meditsinskaya ekologiya. 2015;(4):31–48. (In Russ.).
35. Mukhametgaleeva ED, Popov AV. Primary disability owing to malignant tumors of urban and rural population in Udmurt Republic. Izvestiya Samarskogo nauchnogo tsentra Rossiiskoi akademii nauk. 2015;17(2–3):593–596. (In Russ.).
36. Karol EV, Korneeva SYu, Voinova TA, Shelepin AE, Putova ON, Polyakov DA. Main indicators of primary disability due to diseases caused by malignant neoplasms in Saint Petersburg in 2017-2021. Problems in Oncology. 2022;68(S3):293–294. (In Russ.).
37. Kirichenko YuN, Razinkov DV, Ivanova SI. Incidence of oncological diseases and associated disability in Kursk Region. Kurskii nauchno-prakticheskii vestnik “Chelovek i ego zdorov’e”. 2014;(1):105–109. (In Russ.).
38. Bauer RM, Gozzi C, Hübner W, et al. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011;59(6):985–996. PMID: 21458914. https://doi.org/10.1016/j.eururo.2011.03.020
39. Arustamyan GN. Clinical and economic analysis and its role in managing the quality of health care. Gosudarstvennoe upravlenie. Elektronnyi vestnik. 2011;(29):1. (In Russ.).
40. Federal Law No. 166-ФЗ dated December 15, 2001 “On State Pension Insurance in the Russian Federation”. Accessed October 16, 2024. (In Russ.). http://government.ru/docs/all/97173/
41. Resolution of the Yaroslavl Region Government No. 849-п dated August 29, 2023 “On Establishment of the Minimum Living Wage per Capita and for the Main Socio-Demographic Groups of the Yaroslavl Region Population for Year 2024”. Accessed October 16, 2024. (In Russ.). http://publication.pravo.gov.ru/document/7600202308310006
42. Cylus J, Papanicolas I, Smith PS, eds. Health System Efficiency: How to Make Measurement Matter for Policy and Management. European Observatory on Health Systems and Policies; 2016. PMID: 28783269.
43. Korovkina АА, Ukharskii AV, Nesterov PV, Belonogov SB, Los MS, Shkrebko AN. Physiotherapy for stress urinary incontinence in patients after radical prostatectomy. Medical Science and Education of Ural. 2023;24(2):198–207. (In Russ.).
44. Nesterov PV, Ukharskiy AV, Kislov NV. Regional clinical and economic model of colorectal cancer screening. Research and Practical Medicine Journal. 2020;7(3):146–159. (In Russ.). https://doi.org/10.17709/2409-2231-2020-7-3-15
45. Ignatyeva VI, Derkach EV, Omelyanovsky VV, Avxentyeva MV. The social and economic burden of cancer in the Russian Federation. Medical Technologies. Assessment and Choice. 2013;(4):73–80. (In Russ.).
Review
For citations:
Ukgarskiy A.V., Los M.S., Nesterov P.V., Shakh-Paronyants Yu.S., Kosenko M.V. Cost-Effectiveness Analysis of Rehabilitation Strategies for Patients After Prostate Cancer Surgery. Innovative Medicine of Kuban. 2025;10(2):87-95. (In Russ.) https://doi.org/10.35401/2541-9897-2025-10-2-87-95
Views:
113
Email this article 
